FIA
VTYX

FNY Investment Advisers’s Ventyx Biosciences VTYX Stock Holding History

FNY Investment Advisers’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,000
Closed -$15K – 1520
2025
Q3 		$15K Sell
5,000
-2,500
-33% -$6.62K ﹤0.01% 733
2025
Q2 		$16K Sell
7,500
-2,500
-25% -$4.04K 0.01% 590
2025
Q1 		$11K Hold
10,000
– – 0.01% 485
2024
Q4 		$21K Buy
+10,000
New +$22.7K 0.01% 425
2024
Q2 		– Sell
-13,000
Closed -$71 – 829
2024
Q1 		$71 Buy
+13,000
New +$59.4K 0.04% 223

Other funds holding VTYX

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

FNY Investment Advisers's VTYX Position: Q4 2025 in Review

FNY Investment Advisers sold out of Ventyx Biosciences (VTYX) in Q4 2025, closing a stake of 5,000 shares — an estimated $15K sold.

FNY Investment Advisers first reported a position in VTYX in Q1 2024 and held it in 5 quarters. The position peaked at $21K in Q4 2024. 139 funds tracked by Wall St. Rank hold VTYX as of Q4 2025.

  • FNY Investment Advisers reported no remaining Ventyx Biosciences position as of Q4 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 5,000 Ventyx Biosciences shares in Q4 2025, an estimated $15K.
  • FNY Investment Advisers first reported a position in Ventyx Biosciences in Q1 2024 and held it in 5 quarters.
  • FNY Investment Advisers's Ventyx Biosciences position peaked at $21K in Q4 2024.
  • 139 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.